204 related articles for article (PubMed ID: 32638647)
1. Alternative management of Covid-19 infection.
Atrah HI
Scott Med J; 2020 Aug; 65(3):72-75. PubMed ID: 32638647
[TBL] [Abstract][Full Text] [Related]
2. Proposed use of thalidomide for the cytokine storm of COVID-19.
Goihman-Yahr M
Clin Dermatol; 2020; 38(4):508. PubMed ID: 32972614
[No Abstract] [Full Text] [Related]
3. The association between obesity and poor outcome after COVID-19 indicates a potential therapeutic role for montelukast.
Almerie MQ; Kerrigan DD
Med Hypotheses; 2020 Oct; 143():109883. PubMed ID: 32492562
[TBL] [Abstract][Full Text] [Related]
4. Purposing Saikosaponins for the treatment of COVID-19.
Bahbah EI; Negida A; Nabet MS
Med Hypotheses; 2020 Jul; 140():109782. PubMed ID: 32353743
[No Abstract] [Full Text] [Related]
5. COVID-19: consider cytokine storm syndromes and immunosuppression.
Mehta P; McAuley DF; Brown M; Sanchez E; Tattersall RS; Manson JJ;
Lancet; 2020 Mar; 395(10229):1033-1034. PubMed ID: 32192578
[No Abstract] [Full Text] [Related]
6. Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic.
; Jacob S; Muppidi S; Guidon A; Guptill J; Hehir M; Howard JF; Illa I; Mantegazza R; Murai H; Utsugisawa K; Vissing J; Wiendl H; Nowak RJ
J Neurol Sci; 2020 May; 412():116803. PubMed ID: 32247193
[No Abstract] [Full Text] [Related]
7. Tocilizumab administration in a refractory case of COVID-19.
Dastan F; Nadji SA; Saffaei A; Tabarsi P
Int J Antimicrob Agents; 2020 Aug; 56(2):106043. PubMed ID: 32502524
[No Abstract] [Full Text] [Related]
8. High-Dose Intravenous Immunoglobulins in the Treatment of Severe Acute Viral Pneumonia: The Known Mechanisms and Clinical Effects.
Liu X; Cao W; Li T
Front Immunol; 2020; 11():1660. PubMed ID: 32760407
[TBL] [Abstract][Full Text] [Related]
9. Immunoglobulins in the treatment of COVID-19 infection: Proceed with caution!
Nguyen AA; Habiballah SB; Platt CD; Geha RS; Chou JS; McDonald DR
Clin Immunol; 2020 Jul; 216():108459. PubMed ID: 32418917
[TBL] [Abstract][Full Text] [Related]
10. Dapsone and doxycycline could be potential treatment modalities for COVID-19.
Farouk A; Salman S
Med Hypotheses; 2020 Jul; 140():109768. PubMed ID: 32339778
[No Abstract] [Full Text] [Related]
11. Confronting the controversy: interleukin-6 and the COVID-19 cytokine storm syndrome.
Chen LYC; Hoiland RL; Stukas S; Wellington CL; Sekhon MS
Eur Respir J; 2020 Oct; 56(4):. PubMed ID: 32883678
[TBL] [Abstract][Full Text] [Related]
12. Inflammation resolution: a dual-pronged approach to averting cytokine storms in COVID-19?
Panigrahy D; Gilligan MM; Huang S; Gartung A; Cortés-Puch I; Sime PJ; Phipps RP; Serhan CN; Hammock BD
Cancer Metastasis Rev; 2020 Jun; 39(2):337-340. PubMed ID: 32385712
[TBL] [Abstract][Full Text] [Related]
13. Hazards of the Cytokine Storm and Cytokine-Targeted Therapy in Patients With COVID-19: Review.
Quirch M; Lee J; Rehman S
J Med Internet Res; 2020 Aug; 22(8):e20193. PubMed ID: 32707537
[TBL] [Abstract][Full Text] [Related]
14. Mucous membrane pemphigoid and COVID-19 treated with high-dose intravenous immunoglobulins: a case report.
Daneshpazhooh M; Soori T; Isazade A; Noormohammadpour P
J Dermatolog Treat; 2020 Aug; 31(5):446-447. PubMed ID: 32363963
[TBL] [Abstract][Full Text] [Related]
15. Ursodeoxycholic acid as a candidate therapeutic to alleviate and/or prevent COVID-19-associated cytokine storm.
Abdulrab S; Al-Maweri S; Halboub E
Med Hypotheses; 2020 Oct; 143():109897. PubMed ID: 32505909
[No Abstract] [Full Text] [Related]
16. Treatment considerations for patients with pemphigus during the COVID-19 pandemic.
Shakshouk H; Daneshpazhooh M; Murrell DF; Lehman JS
J Am Acad Dermatol; 2020 Jun; 82(6):e235-e236. PubMed ID: 32283243
[No Abstract] [Full Text] [Related]
17. May IL-17 have a role in COVID-19 infection?
Megna M; Napolitano M; Fabbrocini G
Med Hypotheses; 2020 Jul; 140():109749. PubMed ID: 32339777
[No Abstract] [Full Text] [Related]
18. Hyper-inflammatory Syndrome in a Child With COVID-19 Treated Successfully With Intravenous Immunoglobulin and Tocilizumab.
Balasubramanian S; Nagendran TM; Ramachandran B; Ramanan AV
Indian Pediatr; 2020 Jul; 57(7):681-683. PubMed ID: 32393681
[No Abstract] [Full Text] [Related]
19. The pathogenesis and treatment of the `Cytokine Storm' in COVID-19.
Ye Q; Wang B; Mao J
J Infect; 2020 Jun; 80(6):607-613. PubMed ID: 32283152
[TBL] [Abstract][Full Text] [Related]
20. Amelioration of COVID-19-related cytokine storm syndrome: parallels to chimeric antigen receptor-T cell cytokine release syndrome.
Hoiland RL; Stukas S; Cooper J; Thiara S; Chen LYC; Biggs CM; Hay K; Lee AYY; Shojania K; Abdulla A; Wellington CL; Sekhon MS
Br J Haematol; 2020 Aug; 190(3):e150-e154. PubMed ID: 32584416
[No Abstract] [Full Text] [Related]
[Next] [New Search]